GW Pharmaceuticals - Stock Price History | GWPH

Historical daily share price chart and data for GW Pharmaceuticals since 2019 adjusted for splits. The latest closing stock price for GW Pharmaceuticals as of October 17, 2019 is 119.12.
  • The all-time high GW Pharmaceuticals stock closing price was 187.21 on May 22, 2019.
  • The GW Pharmaceuticals 52-week high stock price is 196.00, which is 64.5% above the current share price.
  • The GW Pharmaceuticals 52-week low stock price is 90.14, which is 24.3% below the current share price.
  • The average GW Pharmaceuticals stock price for the last 52 weeks is 149.46.
GW Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 135.9010 134.0900 174.5000 94.3600 97.3900 -26.23%
2017 113.6863 112.3800 138.7600 94.1400 132.0100 18.13%
2016 89.0206 68.4600 134.0200 36.6400 111.7500 60.93%
2015 96.9463 70.0400 129.6900 64.9600 69.4400 2.60%
2014 72.8060 40.5800 107.3500 38.0600 67.6800 62.93%
2013 18.4218 8.9800 41.5400 8.5100 41.5400 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.680B $0.013B
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Stryker (SYK) United States $80.642B 27.89
Boston Scientific (BSX) United States $53.170B 25.79
Baxter (BAX) United States $44.852B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.438B 18.20
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Cerus (CERS) United States $0.624B 0.00
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Utah Medical Products (UTMD) United States $0.354B 25.91
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00